Evaluation of estrogen receptor α and β and progesterone receptor expression and correlation with clinicopathologic factors and proliferative marker Ki-67 in breast cancers
- 1 May 2008
- journal article
- research article
- Published by Elsevier BV in Human Pathology
- Vol. 39 (5), 720-730
- https://doi.org/10.1016/j.humpath.2007.09.019
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Expression of oestrogen receptor-β in oestrogen receptor-α negative human breast tumoursBritish Journal of Cancer, 2006
- Co-expression of steroid hormone receptors (estrogen receptor α and/or progesterone receptors) and Her2/neu (c-erbB-2) in breast cancer: Clinical outcome following tamoxifen-based adjuvant therapyThe Journal of Steroid Biochemistry and Molecular Biology, 2006
- Distinct mRNA, protein expression patterns and distribution of oestrogen receptors α and β in human primary breast cancer: Correlation with proliferation marker Ki-67 and clinicopathological factorsEuropean Journal of Cancer, 2005
- Clinical significance of estrogen receptor β in breast cancerCancer Chemotherapy and Pharmacology, 2005
- Evaluation of oestrogen receptor β wild-type and variant protein expression, and relationship with clinicopathological factors in breast cancersEuropean Journal of Cancer, 2002
- Studies on oestrogen receptor-α and -β mRNA in breast cancerEuropean Journal of Cancer, 2001
- Primary chemotherapy in locally advanced breast cancer (LABC): effects on tumour proliferative activity, bcl-2 expression and the relationship between tumour regression and biological markersEuropean Journal of Cancer, 1998
- Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 SitesScience, 1997
- ERβ: Identification and characterization of a novel human estrogen receptorFEBS Letters, 1996
- Cloning of a novel receptor expressed in rat prostate and ovary.Proceedings of the National Academy of Sciences of the United States of America, 1996